- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Cipla Reappoints P R Ramesh as Independent Director for Second Term Till 2031

New Delhi: Cipla Limited has announced that its Board of Directors has approved the reappointment of P R Ramesh as an Independent Director of the company for a second consecutive term of five years, subject to shareholders' approval. The new term will commence from July 1, 2026 and continue till June 30, 2031, both days inclusive.
The decision was taken at the meeting of the Board of Directors held on January 23, 2026. Cipla informed stock exchanges that the approval has been granted in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also stated that the detailed information required under the SEBI Listing Regulations read with the SEBI Master Circular dated November 11, 2024, has been provided as part of the disclosure.
P R Ramesh has been associated with Cipla as an Independent Director since July 1, 2021 and currently serves as the Chairman of the company’s Audit Committee. His reappointment is subject to approval by the shareholders of the company.
Ramesh is a Commerce graduate from Osmania University, Hyderabad, and is a Fellow Member of the Institute of Chartered Accountants of India (ICAI). He retired on March 31, 2020, as Director of Deloitte & Touche Assurance & Enterprise Risk Services India Private Limited. During his professional career spanning over 45 years, he has also served as a member of the Deloitte Global Board and Deloitte Asia Pacific Board.
His professional experience spans across multiple sectors including manufacturing, banking and financial services, technology, media, telecommunications, energy and resources, and consumer business. In addition to his role at Cipla, Ramesh serves on the boards of several leading companies such as Air India, Larsen & Toubro (L&T), Nestlé India, Crompton Greaves Consumer Electricals, and ITC Hotels.
Cipla clarified that there is no relationship between P R Ramesh and any other directors of the company. The company further confirmed that Ramesh is not debarred from holding the office of director by virtue of any SEBI order or by any other statutory authority.
According to Cipla Limited, the reappointment reflects the company’s continued focus on strong corporate governance and experienced board leadership.
Also Read: Cipla Emerges as Domestic Contender in Anti-Obesity Market with Yurpeak
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

